Literature DB >> 12297673

At the crossroads of necrosis and apoptosis: signaling to multiple cellular targets by HMGB1.

Michael Bustin1.   

Abstract

Cells can die through two mechanisms: necrosis and apoptosis. Necrosis occurs in response to stimuli that cause cellular damage and result in the release of intracellular proteins, which stimulate the inflammatory response. Necrosis is associated with tissue damage and organ deterioration. Apoptosis is a programmed cell death during which the cellular membrane remains intact, but activated enzymes destroy the cell from within. Bustin discusses how the mobility of the nuclear protein high mobility group B1 (HMGB1) may be a key signal for determining whether certain cells undergo necrotic or apoptotic death. Necrosis may result when HMGB1 is released from the cells and stimulates the inflammatory response. HMGB1 appears to have extracellular signaling functions, such as stimulation of cell motility and tumor metastasis and activation of the cytokine signaling pathways. Through its action on the cytokine signaling targets, HMGB1 may be an important therapeutic target for diseases of cytokine excess, including septic shock.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12297673     DOI: 10.1126/stke.2002.151.pe39

Source DB:  PubMed          Journal:  Sci STKE        ISSN: 1525-8882


  27 in total

Review 1.  Nicotinic modulation of innate immune pathways via α7 nicotinic acetylcholine receptor.

Authors:  Wen-Yan Cui; Ming D Li
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

Review 2.  Scientific and clinical challenges in sepsis.

Authors:  Luis Ulloa; Michael Brunner; Laura Ramos; Edwin A Deitch
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

3.  C/EBP-beta regulates endoplasmic reticulum stress-triggered cell death in mouse and human models.

Authors:  Ofir Meir; Efrat Dvash; Ariel Werman; Menachem Rubinstein
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

4.  High-mobility group box 1 released by autophagic cancer-associated fibroblasts maintains the stemness of luminal breast cancer cells.

Authors:  Xi-Long Zhao; Yong Lin; Jun Jiang; Zhuo Tang; Shuai Yang; Lu Lu; Yan Liang; Xue Liu; Jiao Tan; Xu-Gang Hu; Qin Niu; Wen-Juan Fu; Ze-Xuan Yan; De-Yu Guo; Yi-Fang Ping; Ji Ming Wang; Xia Zhang; Hsiang-Fu Kung; Xiu-Wu Bian; Xiao-Hong Yao
Journal:  J Pathol       Date:  2017-09-21       Impact factor: 7.996

5.  Activation and dramatically increased cytolytic activity of tumor specific T lymphocytes after radio-frequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases.

Authors:  Johannes Hansler; Thaddaus-Till Wissniowski; Detlef Schuppan; Astrid Witte; Thomas Bernatik; Eckhart-Georg Hahn; Deike Strobel
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

6.  The helminth product ES-62 protects against septic shock via Toll-like receptor 4-dependent autophagosomal degradation of the adaptor MyD88.

Authors:  Padmam Puneet; Mairi A McGrath; Hwee Kee Tay; Lamyaa Al-Riyami; Justyna Rzepecka; Shabbir M Moochhala; Shazib Pervaiz; Margaret M Harnett; William Harnett; Alirio J Melendez
Journal:  Nat Immunol       Date:  2011-02-27       Impact factor: 25.606

Review 7.  Targeting HMGB1 in the treatment of sepsis.

Authors:  Haichao Wang; Mary F Ward; Andrew E Sama
Journal:  Expert Opin Ther Targets       Date:  2014-01-06       Impact factor: 6.902

Review 8.  High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.

Authors:  Shu Zhu; Wei Li; Mary F Ward; Andrew E Sama; Haichao Wang
Journal:  Inflamm Allergy Drug Targets       Date:  2010-03

Review 9.  High-mobility group box 1 (HMGB1) in childhood: from bench to bedside.

Authors:  Valeria Chirico; Antonio Lacquaniti; Vincenzo Salpietro; Caterina Munafò; Maria Pia Calabrò; Michele Buemi; Teresa Arrigo; Carmelo Salpietro
Journal:  Eur J Pediatr       Date:  2014-05-09       Impact factor: 3.183

10.  Programmed cellular necrosis mediated by the pore-forming alpha-toxin from Clostridium septicum.

Authors:  Catherine L Kennedy; Danielle J Smith; Dena Lyras; Anjana Chakravorty; Julian I Rood
Journal:  PLoS Pathog       Date:  2009-07-17       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.